Mental Health Programs in Underserved Communities
Supported by Grant from Otsuka America Pharmaceutical, Inc.
ROCKVILLE, Md., March 13, 2006 – The American Psychiatric Foundation (APF) has announced three universities as the inaugural recipients of the Helping Hands Grants. The program encourages medical students to participate in community mental health service activities, particularly those targeting underserved minority communities. The grant program is administered by the American Psychiatric Foundation and supported by an unrestricted educational grant from Otsuka America Pharmaceutical, Inc. (OAPI).
The $5,000 grants have been awarded to the following medical schools to support their community mental health programs:
“We are proud to support the efforts of the inaugural recipients,” said Hiromi Yoshikawa, chairman and chief executive office of Otsuka America Pharmaceutical, Inc. “Otsuka’s support of the Helping Hands Grant program is part of our ongoing commitment to help eliminate health disparities among underserved populations.”
Mental illnesses affect millions of Americans each year, yet with proper treatment, people with mental disorders can lead full and productive lives.
“APF congratulates the medical students whose innovative projects received a grant,” said Steven Rubloff, executive director of the American Psychiatric Foundation. “These students are the future of the psychiatric field, and their efforts are an important step in advancing the mental health of underserved minority populations.”
Support of the Helping Hands Grant Program is part of the Otsuka Minority Health Initiative, an on-going series of strategically integrated activities aimed at reducing inequalities in minority health care. While mental illnesses can affect persons of any age, race, religion, or income level, a profound need exists for improved mental health education and assistance in underserved communities.
Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, innovative, fast-growing healthcare company that commercializes Otsuka-discovered and other product opportunities in North America. OAPI is dedicated to improving patients’ health and the quality of their lives. The company is part of the Otsuka Pharmaceutical Group, which is comprised of 81 companies and approximately 26,000 people around the world. With 39 consolidated subsidiaries, Otsuka earned US$6.2 billion in consolidated annual revenues in fiscal 2004. For additional information, please visit www.otsuka.com.
The American Psychiatric Foundation is the philanthropic and educational arm of the American Psychiatric Association. The mission is to advance understanding that mental illnesses are real and can be effectively treated. For more information on the American Psychiatric Foundation, please visit www.psychfoundation.org.
Otsuka America Pharmaceutical, Inc.
2440 Research Boulevard Rockville, Maryland 20850
Contact:
Debra Kaufmann
Otsuka America Pharmaceutical, Inc.
240.683.3568
debra.kaufmann@otsuka.com
Tara Burkholder
American Psychiatric Foundation
703.907.8516
tburkholder@psych.org